title: Attenuation of the vasoconstrictor action of neuropeptide-Y by calcium-channel blockers.
abstract: Neuropeptide-Y (NPY) was administered intracoronarily in dogs to see the modification of its vasoconstrictor action by the calcium (Ca)-channel blockers nisoldipine (0.1 microgram/kg) and nifedipine (1 microgram/kg). Dogs were anesthetized and the left circumflex artery was cannulated without opening the chest by using a specially designed cannula perfused at constant pressure. The change in coronary flow due to NPY was determined before and after the systemic administration of the two Ca-channel blockers. With administration of 1 to 2 nmol of NPY, coronary blood flow decreased maximally by 23.4 +/- 7.8% without changes in perfusion pressure or central venous pressure and it became significantly less after nisoldipine: 16.0 +/- 5.7% (p less than 0.02). A similar attenuation in the decrease in coronary flow was observed in the nifedipine study: 23.2 +/- 7.5% to 12.0 +/- 6.7% (p less than 0.02). A fall in systemic arterial blood pressure was observed after administration of both Ca-channel blockers, but it was significant only after nisoldipine (p less than 0.01). Nonsignificant increases in heart rate were observed after both drugs. Nisoldipine seemed to attenuate the NPY-induced vasoconstriction in dogs, and its equimolar potency is about ten times that of nifedipine.
authors: First Department of Internal Medicine, Niigata University, Japan.
authors: Y
authors: Y
authors: Aizawa
authors: S
authors: S
authors: Niwano
authors: M
authors: M
authors: Aizawa
authors: M
authors: M
authors: Tamura
authors: A
authors: A
authors: Shibata
mesh_terms: D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects; D004285:Dogs; D009478:Neuropeptide Y / Q000494:pharmacology*; D014661:Vasoconstriction / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology
chemical_list: D002121:Calcium Channel Blockers; D009478:Neuropeptide Y; D014662:Vasoconstrictor Agents